Daiwa Securities Group’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$645K Buy
3,737
+1,488
+66% +$257K ﹤0.01% 812
2025
Q1
$351K Hold
2,249
﹤0.01% 881
2024
Q4
$309K Sell
2,249
-68
-3% -$9.34K ﹤0.01% 909
2024
Q3
$346K Hold
2,317
﹤0.01% 905
2024
Q2
$316K Sell
2,317
-162
-7% -$22.1K ﹤0.01% 904
2024
Q1
$375K Sell
2,479
-151
-6% -$22.8K ﹤0.01% 880
2023
Q4
$331K Sell
2,630
-124
-5% -$15.6K ﹤0.01% 885
2023
Q3
$258K Sell
2,754
-108
-4% -$10.1K ﹤0.01% 920
2023
Q2
$255K Sell
2,862
-97
-3% -$8.64K ﹤0.01% 914
2023
Q1
$317K Sell
2,959
-92
-3% -$9.86K ﹤0.01% 877
2022
Q4
$372K Buy
3,051
+29
+1% +$3.54K ﹤0.01% 857
2022
Q3
$312K Sell
3,022
-76
-2% -$7.85K ﹤0.01% 881
2022
Q2
$288K Buy
3,098
+409
+15% +$38K ﹤0.01% 914
2022
Q1
$316K Buy
2,689
+368
+16% +$43.2K ﹤0.01% 931
2021
Q4
$313K Sell
2,321
-302
-12% -$40.7K ﹤0.01% 934
2021
Q3
$419K Buy
2,623
+425
+19% +$67.9K ﹤0.01% 877
2021
Q2
$290K Sell
2,198
-314
-13% -$41.4K ﹤0.01% 902
2021
Q1
$323K Sell
2,512
-90
-3% -$11.6K ﹤0.01% 882
2020
Q4
$434K Buy
2,602
+2,338
+886% +$390K ﹤0.01% 789
2020
Q3
$41K Buy
264
+5
+2% +$777 ﹤0.01% 942
2020
Q2
$29K Hold
259
﹤0.01% 994
2020
Q1
$29K Hold
259
﹤0.01% 976
2019
Q4
$36K Sell
259
-32
-11% -$4.45K ﹤0.01% 972
2019
Q3
$28K Buy
291
+7
+2% +$674 ﹤0.01% 971
2019
Q2
$33K Buy
284
+28
+11% +$3.25K ﹤0.01% 975
2019
Q1
$30K Sell
256
-21
-8% -$2.46K ﹤0.01% 966
2018
Q4
$17K Buy
277
+100
+56% +$6.14K ﹤0.01% 963
2018
Q3
$13K Hold
177
﹤0.01% 1005
2018
Q2
$12K Hold
177
﹤0.01% 1029
2018
Q1
$12K Buy
+177
New +$12K ﹤0.01% 1006